Holen Sie sich die Stockscreener-App
25.99
1.84%
0.47
Handel nachbörslich:
25.99
Amphastar Pharmaceuticals Inc Aktie (AMPH) Neueste Nachrichten
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Sees Large Increase in Short Interest - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $3.09 Million Stock Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Squarepoint Ops LLC Has $656,000 Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Director Sells $12,835.00 in Stock - MarketBeat
Amphastar Pharmaceuticals director sells $12,835 in stock - Investing.com Australia
Amphastar at Jefferies Conference: Strategic Focus on Growth - Investing.com Australia
Global Antidote Market to Cross the USD 4 Billion Mark by 2032 | DelveInsight - GlobeNewswire Inc.
Nuveen Asset Management LLC Sells 112,307 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals director sells $12,835 in stock By Investing.com - Investing.com South Africa
Amphastar Pharmaceuticals Stockholders Approve Key Amendments - TipRanks
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Short Interest Up 24.9% in May - Defense World
Nuveen Asset Management LLC Has $3.55 Million Stock Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar price target lowered to $35 from $40 at Wells Fargo - MSN
Two Sigma Advisers LP Sells 12,400 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
(AMPH) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Man Group plc Buys New Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Bought by Voloridge Investment Management LLC - MarketBeat
Deutsche Bank AG Buys 10,839 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Point72 Asset Management L.P. Sells 29,617 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Evolent Health, Amphastar Pharmaceuticals, Iridium, and Magnite Stocks Trade Up, What You Need To Know - Yahoo Finance
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Acquires 792 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Twinbeech Capital LP Invests $1.74 Million in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Deutsche Bank AG Has $1.27 Million Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Ameriprise Financial Inc. Grows Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by BNP Paribas Financial Markets - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Bought by Janus Henderson Group PLC - MarketBeat
D. E. Shaw & Co. Inc. Buys 95,192 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Systematic Financial Management LP Makes New $9.15 Million Investment in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Generic Pharmaceuticals Stocks Q1 In Review: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs Peers - FinancialContent
Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference - ACCESS Newswire
Amphastar CFO to Lead Fireside Chat at Jefferies Global Healthcare Conference June 5 - Stock Titan
When the Price of (AMPH) Talks, People Listen - news.stocktradersdaily.com
BNP Paribas Financial Markets Sells 57,502 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Northern Trust Corp Acquires 29,808 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Jane Street Group LLC Raises Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals' (AMPH) "Neutral" Rating Reaffirmed at JPMorgan Chase & Co. - MarketBeat
Comerica Bank Cuts Stock Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by The Manufacturers Life Insurance Company - Defense World
Amphastar Pharmaceuticals (NASDAQ:AMPH) Given “Neutral” Rating at JPMorgan Chase & Co. - Defense World
Amphastar outlines key launches and product growth drivers for 2025 - MSN
Amphastar Pharma (AMPH) Downgraded by JP Morgan with Revised Pri - GuruFocus
This Target Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday - Benzinga
Amphastar stock rating cut to Neutral by JPMorgan - Investing.com Canada
3.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):